
    
      Design: A single-blind randomized controlled trial will be conducted on patients with FMS.

      Methods: Sixty-four subjects with FMS will be randomly assigned to an experimental group
      receiving dry needling therapy, or to a control group for myofascial release therapy in the
      trigger points active or latent in the following pairs of muscles: occipital, splenius
      capitis, sternocleidomastoid, scalene, trapezius, supraspinatus, infraspinatus, and
      multifidus. Myofascial trigger points, quality of life, impact of fibromyalgia symptoms,
      quality of sleep, intensity of pain, anxiety levels, state of depression, impact of fatigue
      will be recorded at baseline and after four weeks of treatment.
    
  